MEI Pharma Allocates $100 Million to Litecoin in Institutional Treasury First
MEI Pharma (NASDAQ: MEIP) has invested $100 million in Litecoin as its primary treasury reserve asset, marking the first such allocation by a U.S.-listed company. The unprecedented move positions Litecoin alongside traditional treasury holdings while signaling growing institutional diversification beyond… Read More »MEI Pharma Allocates $100 Million to Litecoin in Institutional Treasury First